• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ReNeuron Group - Articles and news items

ReNeuron Group publishes stroke clinical data

Industry news / 4 August 2016 / Niamh Louise Marriott, Digital Content Producer

The PISCES I study was the first clinical trial of ReNeuron’s CTX cell therapy candidate for patients with motor disability as a consequence of ischaemic stroke. The data, collated over two years relates to the eleven stroke patients treated in the study…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +